Nanobiotix S.A. (0QAV.L)

EUR 3.0

(0.33%)

Operating Expenses Summary of Nanobiotix S.A.

Nanobiotix S.A.'s latest annual operating expenses in 2023 was 62.98 Million EUR , up 28.56% from previous year.
Nanobiotix S.A.'s latest quarterly operating expenses in 2024 Q2 was 32.94 Million EUR , down 0.0% from previous quarter.
Nanobiotix S.A. reported a annual operating expenses of 48.99 Million EUR in annual operating expenses 2022, up 1.54% from previous year.
Nanobiotix S.A. reported a annual operating expenses of 48.25 Million EUR in annual operating expenses 2021, up 29.76% from previous year.
Nanobiotix S.A. reported a quarterly operating expenses of 27.92 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Nanobiotix S.A. reported a quarterly operating expenses of 41 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Nanobiotix S.A. (2023 - 2012)

Historical Annual Operating Expenses of Nanobiotix S.A. (2023 - 2012)

Year	Operating Expenses	Operating Expenses Growth
2023	62.98 Million EUR	28.56%
2022	48.99 Million EUR	1.54%
2021	48.25 Million EUR	29.76%
2020	37.18 Million EUR	-21.7%
2019	47.49 Million EUR	44.01%
2018	32.97 Million EUR	15.13%
2017	28.64 Million EUR	7.36%
2016	26.67 Million EUR	28.28%
2015	20.79 Million EUR	67.87%
2014	12.38 Million EUR	26.74%
2013	9.77 Million EUR	59.05%
2012	6.14 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	32.94 Million EUR	0.0%
2023 Q2	27.92 Million EUR	0.0%
2023 Q4	41 Million EUR	0.0%
2023 FY	58.92 Million EUR	20.28%
2022 Q4	23.49 Million EUR	0.0%
2022 FY	48.99 Million EUR	1.54%
2022 Q2	25.5 Million EUR	0.0%
2021 Q4	23.37 Million EUR	0.0%
2021 Q2	24.88 Million EUR	0.0%
2021 FY	48.25 Million EUR	29.76%
2020 FY	37.18 Million EUR	-21.7%
2020 Q2	19.03 Million EUR	0.0%
2020 Q4	18.26 Million EUR	0.0%
2019 Q4	25.99 Million EUR	0.0%
2019 Q2	21.49 Million EUR	0.0%
2019 FY	47.49 Million EUR	44.01%
2018 FY	32.97 Million EUR	15.13%
2018 Q4	18.5 Million EUR	0.0%
2018 Q2	14.5 Million EUR	0.0%
2017 Q2	14.03 Million EUR	0.0%
2017 FY	28.64 Million EUR	7.36%
2017 Q4	15.75 Million EUR	0.0%
2016 Q2	13.1 Million EUR	0.0%
2016 FY	26.67 Million EUR	28.28%
2016 Q4	14.06 Million EUR	0.0%
2015 FY	20.79 Million EUR	67.87%
2015 Q4	11.59 Million EUR	0.0%
2015 Q2	9.54 Million EUR	0.0%
2014 FY	12.38 Million EUR	26.74%
2014 Q2	5.2 Million EUR	0.0%
2014 Q4	7.18 Million EUR	0.0%
2013 Q4	4.81 Million EUR	0.0%
2013 Q2	4.95 Million EUR	0.0%
2013 FY	9.77 Million EUR	59.05%
2012 Q3	1.58 Million EUR	0.0%
2012 FY	6.14 Million EUR	0.0%
2012 Q4	1.58 Million EUR	0.0%

Peer Operating Expenses Comparison of Nanobiotix S.A.

Name	Operating Expenses	Operating Expenses Difference
Boiron SA	317.27 Million EUR	80.147%
Laboratorios Farmaceuticos Rovi, S.A.	263.09 Million EUR	76.059%
Vetoquinol SA	217.11 Million EUR	70.989%
Valneva SE	134.92 Million EUR	53.317%
AB Science S.A.	14.01 Million EUR	-349.394%
PHAXIAM Therapeutics S.A.	24.98 Million EUR	-152.089%
Vivoryon Therapeutics N.V.	24.69 Million EUR	-155.091%
BioSenic S.A.	7.58 Million EUR	-730.634%
ABIVAX Société Anonyme	127.37 Million EUR	50.55%
Formycon AG	23.73 Million EUR	-165.398%